LOS ANGELES, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, today announced that it has recently closed four new payor contracts with national Preferred Provider Organization (“PPO”) networks. The four new provider agreements are with:
America’s Choice Provider Network, LLC
FedMed, Inc.
Galaxy Health Network
Prime Health Services, Inc.
Help employers find you! Check out all the jobs and post your resume.
